In a young male with low serum testosterone (7.1 nmol/L) and symptoms of decreased libido and fatigue, what intramuscular testosterone replacement regimen should be used?

IM Testosterone Regimen for Young Male with Low Testosterone (7.1 nmol/L)

Start with testosterone enanthate or cypionate 75-100 mg intramuscularly weekly, or 150-200 mg every 2 weeks, aiming for mid-normal testosterone levels (400-700 ng/dL or 14-24 nmol/L). 1

Initial Dosing Strategy

The Endocrine Society guidelines provide clear dosing parameters for IM testosterone replacement 1:

• Weekly regimen: 75-100 mg testosterone enanthate or cypionate IM
• Biweekly regimen: 150-200 mg testosterone enanthate or cypionate IM every 2 weeks
• Alternative approach: 100 mg on days 1,11, and 21 of each month 2

Weekly dosing is preferable for this young patient because smaller, more frequent injections maintain more stable testosterone levels within the normal range and minimize the peak-trough fluctuations that can cause mood swings and libido changes 2, 3. The traditional every-2-to-3-week dosing of 200-300 mg creates problematic fluctuations in serum testosterone that may worsen symptoms between injections 2.

Target Testosterone Levels

Aim for serum testosterone levels in the mid-normal range during treatment 1:

• Target: 400-700 ng/dL (14-24 nmol/L) measured 1 week after injection for enanthate/cypionate 1
• Check testosterone levels 3-6 months after initiation, then adjust dosing based on trough levels (just before next injection) 1

Pre-Treatment Evaluation Required

Before initiating testosterone therapy, obtain 1:

• Baseline hematocrit (contraindicated if >50%)
• Digital rectal exam and PSA if age ≥40 years or baseline PSA >0.6 ng/ml
• Prostate assessment: Do not start if palpable nodule, PSA >3-4 ng/ml, or severe BPH symptoms (IPSS >19)
• Screen for untreated sleep apnea and severe heart failure (relative contraindications)

Monitoring Schedule

Follow this algorithmic monitoring approach 1:

At 3-6 Months:

• Assess symptom improvement (libido, fatigue, erectile function)
• Measure testosterone level (trough level just before next injection)
• Check hematocrit (stop if >54%, evaluate for hypoxia/sleep apnea, restart at reduced dose when safe)
• PSA and digital rectal exam (if age ≥40)

Annually Thereafter:

• Symptom assessment and compliance check
• Hematocrit monitoring
• PSA and prostate exam (age-appropriate screening)
• Testosterone level if symptoms recur or dosing changes needed

Urological Referral Triggers:

Obtain immediate urology consultation if 1:

• PSA increase >1.4 ng/ml within any 12-month period
• PSA velocity >0.4 ng/ml/year (after 6 months of therapy, with >2 years data)
• Abnormal digital rectal exam
• IPSS score >19

Dose Adjustment Strategy

If symptoms persist at 3-6 months despite treatment 1:

• Check trough testosterone level (just before next injection)
• If trough <400 ng/dL (14 nmol/L): increase dose by 25-50 mg per injection
• If trough >700 ng/dL (24 nmol/L) with side effects: decrease dose
• Consider switching to more frequent injections (e.g., twice weekly at lower doses) if patient reports symptom cycling or peak-related side effects like acne, mood swings, or fluid retention 3

Common Pitfalls to Avoid

Do not measure testosterone at random times - timing matters critically for injectable esters. For enanthate/cypionate, measure 1 week after injection or just before the next dose (trough level) 1. Peak levels occur 24-48 hours post-injection and are not representative of steady-state replacement.

Do not continue therapy without monitoring hematocrit - erythrocytosis is the most common dose-dependent adverse effect and requires dose reduction or temporary cessation if hematocrit exceeds 54% 1.

Do not ignore fluctuating symptoms between injections - this indicates excessive peak-trough variation. The solution is more frequent injections at lower doses per injection (maintaining the same total weekly dose), not simply increasing the dose 2, 3.

Expected Outcomes

This patient should expect 1, 4:

• Libido improvement: Significant benefit demonstrated in men with testosterone <10.4 nmol/L and low libido
• Erectile function: Modest improvement, though phosphodiesterase-5 inhibitors remain first-line for ED
• Energy and mood: Moderate improvements in fatigue and well-being
• Body composition: Increased lean mass, decreased fat mass over 6-12 months

The FDA-approved dosing for testosterone cypionate is 50-400 mg every 2-4 weeks 5, but the guideline-recommended approach of smaller, more frequent doses provides superior symptom control and safety profile 2, 1.